Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combination of **L-glutamine**, **calcium**, and **magnesium** intended as a dietary supplement to support normal muscle and nerve function, energy metabolism, bone health, and potentially recovery or antioxidant activity. Glutamine is a non-essential amino acid involved in protein synthesis, immune function, and energy provision for rapidly dividing cells. Magnesium plays roles in energy metabolism, muscle and nerve function, and electrolyte balance, while calcium is crucial for bone structure, nerve transmission, and muscle contraction. This combination is commonly marketed to athletes and individuals with increased nutritional needs, but is not approved as a pharmaceutical drug. The mechanisms of action are nutritional supplementation of essential minerals (calcium, magnesium) and glutamine, supporting physiological functions rather than pharmacological targeting of disease pathways[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glutamine + calcium + magnesium.